Aim: The aim of this study is to identify and evaluate problems in regional tuberculosis control studies, using an international tuberculosis indicator. Methods: In this retrospective cohort study, the records of a total of 1,776 patients diagnosed with tuberculosis, followed up and treated from 2004−2008 in Mersin were evaluated. Indicators recommended by the World Health Organization were used as assessment criteria. Descriptive statistics were used to summarize data. The Mantel-Haenszel test was used for calculation of the risk between urban/rural, and between male/ female which were in different age groups.
INTRODUCTION
Global efforts to control tuberculosis (TB) were reinvigorated in 1991, when a World Health Assembly resolution recognized TB as a major global public health problem (1) . The World Health Organization (WHO) declared tuberculosis a global emergency in 1993 (2) . The latest assessment of the global burden of TB in 2009 estimate 9.4 million incident cases, 14.0 million prevalent cases, and 1.7 million deaths (3). Globally, TB incident rates peaked at 142 cases per 100000 population in 2004. There were an estimated 139 incident cases per 100000 population in 2007 and 137 cases per 100000 population in 2009 (3−5) . However, global incidence rates have been declining since 2004 (3) . Incidence rates are falling in five of the six WHO regions (with the exception of the European region, where rates remain relatively stable). In Turkey, which is classified in the European region by WHO, the incidence rate declined from 33/100000 to 29/100000 beginning from 2005 to 2009. Turkey is one of 36 countries which achieved the target of the World Health Assembly by detecting 70% of smear positive cases with directly observed treatment (DOTS) programmes and treated 85% of them successfully (5) . The treatment success was 86% in the world, 66% in Europe and 92% in Turkey in 2008 (3) .
Routine monitoring of TB control is crucial in order to understand trends in the TB epidemic and progresses in TB control (4−5) . Following are the main indicators used to monitor the progress in TB control up to 2015: trends in incidences, prevalence and mortality, treatment success rate and the case detection rate for all forms of TB. Use of the case detection rate for smear positive TB should be phased out (3) . The overall purpose of monitoring and evaluation is to measure programme effectiveness, identify problem areas, take note of the lessons learned, and improve the overall performance. The indicators are routinely calculated by TB control programmes at district, regional, and national levels. They are used to monitor progress towards the achievement of the national targets for case detection and treatment outcomes, and also to monitor programme quality and effectiveness (6) . TB has been controlled over the years at global and national levels with the programmes launched; however, there are differences between regions with regards to TB indicators recorded.
Due to epidemiological properties of the disease, tuberculosis control requires conducting of long-standing programmes, and reporting of programme results with globally, nationally and locally measurable and comparable indicators (7) . The aim of this study was to determine TB trends, to evaluate effectiveness of regional TB control studies and to detect problems in the control studies carried out from 2004−2008 in Mersin, which is located in the southern part of Turkey. 
METHODS

Study Type and Study Period
Our study is a retrospective cohort study. Data was collected in July and August of 2009. However, treatment outcomes of patients whose treatment had not been terminated were completed in July and August 2010.
Study Population and Data Collection
The Mersin province is located in the Mediterranean region of Turkey with a population of 1.5 million. There is approximately 321 km distance between the eastern and western borders of the province (8−13). The diagnosis and treatment of TB patients in Mersin were conducted in four distinct TB dispensaries. These four dispensaries are located in Tarsus, a centre in the eastern part of the province and in Silifke and Anamur in the West. The records of all patients diagnosed with TB and treated in these dispensaries between 01 January 2004 and 31 December 2008 were taken as the study population. A total of 1,846 patient applications were entered into the computer. Fifty-three of them were excluded from the data set as they were diagnosed with something else than TB. 17 patients were recorded in two distinct dispensaries at the same time,therefore one of them was excluded from the study. In our study, dispensary records of 1,776 TB patients were evaluated.
In Turkey, treatment, follow ups and recording of all TB patients are conducted by TB dispensaries. This is important for recording and for records accuracy. Sputum smear and radiology are available for TB diagnosis in TB dispensaries in Turkey (14) . DOTS for TB control began in June 2006 in Mersin and throughout the rest of Turkey (15) .
Statistical Analyses
The analyses were performed with data sets and the standards defined by WHO (5). In our study, indicators recommended by WHO were used for evaluation of the TB control programme applied in our region (6) . The number of TB cases obtained from the records was used for calculation of the annual case notification rates (CNR). For demographic data, mid-year household population number obtained from the Local Health Authority in Mersin was used. The populations according to years were as follows: 1,522,934; 1,551,176; 1,581,446; 1,608,259 and 1,546,391 (8−12) .
In addition to these indicators, the distribution of new CNR according to residential area, gender and age groups of the previous five years was calculated. The risks between urban/rural and male/female for new cases were calculated by the Mantel Haenszel Test. Whether the odds ratio (OR) values obtained as a result of the Mantel Haenszel Test differed significantly was evaluated with the Breslow-Day statistics. The risk between the age groups for new cases was calculated by the Chi-Square Linear-by-Linear Association analyses. In addition to this, the median age distributions of cases according to years were calculated individually for both males and females. (Table 1) .
RESULTS
In
Notification and Diagnosis
New CNR reduced both in urban and rural areas and in both genders in a five-year period. An increase in CNR in those aged over 55 years was compensated by the declining trend in childhood, adolescence and middle age groups ( Table 2) .
The median age of new TB cases was changed from 31 to 36 across the whole group, and from 33 to 37 in males, and from 27 to 35 in females. (Table 2) .
A similar rate of new TB cases was detected in both urban and rural areas for all years and the OR value did not change significantly over the years (p=0.257). In our region, the TB development risk was estimated to be the same in urban and rural areas between 2004 and 2008 (in homogenous group, Mantel-Haensel Test; OR=1.0, 95% CI, 0.863−1.112, p=0.810). For each year, TB was detected as being more frequent among males compared to females and male/female OR values were found not to change significantly (p=0.581). For all years, the TB rate was estimated to be twice as high in males compared to females (in homogenous group, Mantel-Haensel Test; OR=2.0, 95% CI, 1.783−2.195, p=0.001). The yearly distribution of TB risk related to residential area and gender is given in Table 3 .
The number of new adult smear positive TB cases increased considerably in 2006; however, it declined again in 2008. In contrast, the new PTB cases with no smear results decreased in 2006 and increased again in 2008. A reduction was seen in the sputum conversion rate at the end of the initial phase of treatment and new TB cases with no smear conversion result rate in the five-year period (Table 1) .
Treatment Outcomes
In our study, it was observed that the treatment success rate and cure rate increased in the five years. During this period, a reduction was seen in the treatment completion rate; death rate, treatment failure rate, default rate, and transfer out rate (Table 1, Fig. 1 ). Among retreated cases, the number of treatment failures was one in 2004 and one in 2006. However, apart from the aforementioned periods, all re-treated patients were seen to make a complete recovery. In our region, the number of patients under DOTS rate was zero in 2004 and 2005, but increased after 2006 (Table 1) .
DISCUSSION
Notification and Diagnosis
In the 2010 WHO report, the TB notified new and relapse rate was reported to have risen to 85/100000 from 79/100000 globally. However, it decreased to 38/100000 from 41/100000 in the European region and to 24/100000 from 28/100000 in Turkey between 2005 and 2008 (3). In the study by Dye (16) evaluating data from 134 countries, CNR was reported to decrease over time, and Falzon (17) Balbay et al. (18) reported that a ratio of new TB cases is similarly in urban and rural areas and Akgün et al. (19) reported that it was twice as high in urban areas compared to rural areas. In our study, the new TB case rate was found to be similar to that of Balbay et al. in urban and rural areas. In our region, the fact that the risk of developing TB was similar in urban and rural areas between 2004 and 2008, and the new CNR decline over the years, indicates that this problem is common for both urban and rural areas and that TB control studies were conducted with the same amount of effectiveness in the whole region.
The male ratio was reported to be between 2.0 and 2.8 (18, 20−23) . Also in our study, twice as high risk of TB in males compared to females is similar to other published reports and studies. We believe that reason for higher prevalence of TB in males arises from the different biological factors and social roles of males and females. In studies investigating the distribution of TB according to age groups, a reduction in incidence rates was seen in younger age groups and increased in the elderly (14, 20, 22, 24−26) . In our region, TB decreases in childhood compared to other age groups and the median age of new TB cases increase in those years may indicate decrease of the infection in childhood and adolescence. The reduction in childhood suggests that TB infection risk decreases in this age group in our region (27) .
In recent years, new smear positive pulmonary TB CNR obtained in our study is in decline -a trend similar to the global one. In our study, it is seen that one-fifth of TB cases were diagnosed without making a sputum smear and sputum microscopy was not studied at the end of the initial phase in one-fifth of the cases diagnosed. However, out of the total sputum microscopies performed 40% of the cases remain positive after the initial phase. Despite the fact that sputum samples should be examined from all patients under suspicion of PTB (28) if the microscopy laboratory is available, smear positive cases should constitute at least 65% of PTB cases in adults (6) . However, it was observed that these ratios could not be achieved in our region. In our study, a new PTB case with a no smear result rate is higher than that recorded in Turkey (32.9%, 21.4%, 16.2%, 11.2%, 11.4% for 2004−2008, respectively) (7, 14) . Therefore, it can be stated that, in terms of bacteriological examination, there is a problem in our region as some cases had been diagnosed only radiologically without the support of sputum microscopy. An increase of sputum microscopy use in TB diagnosis after 2006 may be attributed to the effect of DOTS implementation.
While most of the new smear positive PTB patients should become negative after two or three months of therapy (6) , it may be concluded that the reason for approximately 40% of the cases staying positive may be due to poor treatment compliance, and a lack of sputum samples obtained at the end of initial phase because of technical or staff problems and due to a poor DOTS. In our study, new extrapulmonary TB (EPTB) case rate is above the recommended 10−15% ratio (6) in the world in general and Europe in particular, and below the rate showed in Turkey (3). High EPTB case rate in our region with no noticeable reduction over the years points to the need for EPTB research here.
Treatment Outcomes
In our study, treatment success rate recommended for determining quality and efficacy of the national TB control programme (6) has been above both 85%, which is the recommended threshold level (5) , and the mean value for the world (3) since 2005. Further, the treatment rate has gradually increased over the years. This condition indicates capacity of the TB control programme for securing the patient during a course of chemotherapy and the success of treatment process.
The cure rate accepted as safer and more valuable indicator than treatment success rate (6) was approximately 80% in the world at large, 60% in Europe and Turkey between 2005 and 2008, and has been noted to increase since (3). In our study, it was observed that the cure rate is higher than in Europe and Turkey, lower than in the world at large and with similar increase in the period of the study. In Mersin from 2004 to 2008, the reduction in the death rate, treatment failure rate, default rate, transfer out rate and increase in the DOTS implementation had significant effects on the increase of treatment success and cure rate.
Treatment completion rate was reported to be 7% in the world between 2005 and 2008 and remained constant, reduced to 8% from 13% in Europe and to 33% from 44% in Turkey, respectively (3). In our study, treatment completion rate in Mersin was higher than the value in the world and Europe and lower than that of Turkey. Again, in our Mersin study, while treatment completion rate declined during the five-year period, the cure rate increased, which is important in terms of indicating increase in the number of microbiological analyses rate at the beginning and end of therapy.
The percentage of basal value of the total negative results (death rate, treatment failure rate, default rate) for the new smear positive cases was 15% (6). In our study, the sum of three indicators is below the value of the world, Europe and Turkey (3) and the recommended basal limit. The sum of negative results reduction to half from 2004 (12%) to 2008 (6%) indicates increase of both treatment success and the success of DOTS applications in our region.
Progress in DOTS implementation is reported to be 83%, 89%, 93%, 94% and 46%, 59%, 67%, 75% globally and in Eu- The national TB control program and policy prepared by the Ministry of Health in light of the recommendations of WHO was accurately applied in Mersin (14) . As records of all TB patients in our region could be accessed, the evaluation of the program held in Mersin and its suburbs may give us an idea regarding TB control studies in Turkey and the results obtained from our region may be generalized for the whole of the country.
Limitations of the Research
The retrospective nature of the study is a limitation as not all TB cases are registered by health institutions for diagnosis and treatment. Though the same physicians were participating in the study, their differing attitudes and systems in terms of producing medical records may have lead to insufficient accuracy. Additionally, the technical staff carrying out smear microscopic examinations may have interpret the results differently.
CONCLUSION
In conclusion, our study demonstrated that a sputum smear microscopy is inadequately used for the diagnosis and treatment of tuberculosis. Furthermore, the increase in cure rates over the years is insufficient. In order to solve this problem, the ratio of sputum smear should be increased up to 100%, especially when diagnosing PTB in adults and follow up of cases. In our study, it was observed that we face considerable problems in TB control studies. In the light of our findings, we recommend that TB control studies be monitored and evaluated employing the recommended tuberculosis indicators.
